Stock Yards Bank & Trust’s AbbVie ABBV Stock Holding History

Stock Yards Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.6M	Sell	57,876 -3,045	-5%	-$675K	0.39%	59
2025 Q4	$13.9M	Sell	60,921 -282	-0.5%	-$64.2K	0.43%	52
2025 Q3	$14.2M	Sell	61,203 -1,612	-3%	-$328K	0.44%	51
2025 Q2	$11.7M	Buy	62,815 +572	+0.9%	+$106K	0.39%	56
2025 Q1	$13M	Sell	62,243 -2,429	-4%	-$472K	0.46%	55
2024 Q4	$11.5M	Sell	64,672 -10,343	-14%	-$1.9M	0.39%	58
2024 Q3	$14.8M	Sell	75,015 -1,465	-2%	-$273K	0.48%	56
2024 Q2	$13.1M	Sell	76,480 -1,905	-2%	-$316K	0.43%	59
2024 Q1	$14.3M	Sell	78,385 -5,384	-6%	-$928K	0.47%	57
2023 Q4	$13M	Sell	83,769 -502	-0.6%	-$73.2K	0.46%	56
2023 Q3	$12.6M	Buy	84,271 +1,380	+2%	+$203K	0.48%	56
2023 Q2	$11.2M	Sell	82,891 -1,127	-1%	-$165K	0.41%	60
2023 Q1	$13.4M	Sell	84,018 -1,725	-2%	-$264K	0.51%	53
2022 Q4	$13.9M	Sell	85,743 -854	-1%	-$131K	0.54%	48
2022 Q3	$11.6M	Buy	86,597 +1,412	+2%	+$203K	0.5%	54
2022 Q2	$13M	Buy	85,185 +38,365	+82%	+$5.86M	0.54%	51
2022 Q1	$7.59M	Sell	46,820 -318	-0.7%	-$46.2K	0.42%	60
2021 Q4	$6.38M	Buy	47,138 +9,538	+25%	+$1.13M	0.34%	63
2021 Q3	$4.06M	Buy	37,600 +878	+2%	+$100K	0.26%	64
2021 Q2	$4.14M	Sell	36,722 -599	-2%	-$67.5K	0.26%	63
2021 Q1	$4.04M	Sell	37,321 -974	-3%	-$104K	0.27%	63
2020 Q4	$4.1M	Sell	38,295 -567	-1%	-$54.5K	0.3%	60
2020 Q3	$3.4M	Sell	38,862 -2,126	-5%	-$200K	0.28%	62
2020 Q2	$4.02M	Sell	40,988 -224	-0.5%	-$19.7K	0.36%	56
2020 Q1	$3.14M	Sell	41,212 -243	-0.6%	-$20.7K	0.33%	60
2019 Q4	$3.67M	Buy	41,455 +449	+1%	+$37.3K	0.31%	65
2019 Q3	$3.1M	Sell	41,006 -142	-0.3%	-$9.73K	0.28%	68
2019 Q2	$2.99M	Buy	41,148 +688	+2%	+$54.1K	0.28%	68
2019 Q1	$3.26M	Sell	40,460 -718	-2%	-$58.7K	0.32%	66
2018 Q4	$3.8M	Sell	41,178 -409	-1%	-$36K	0.42%	59
2018 Q3	$3.93M	Buy	41,587 +1,141	+3%	+$108K	0.4%	57
2018 Q2	$3.75M	Sell	40,446 -835	-2%	-$81.5K	0.41%	57
2018 Q1	$3.91M	Sell	41,281 -694	-2%	-$76.2K	0.44%	56
2017 Q4	$4.06M	Sell	41,975 -85	-0.2%	-$8.01K	0.45%	57
2017 Q3	$3.74M	Sell	42,060 -35	-0.1%	-$2.66K	0.44%	58
2017 Q2	$3.05M	Buy	42,095 +2,586	+7%	+$174K	0.37%	63
2017 Q1	$2.57M	Sell	39,509 -2,033	-5%	-$128K	0.33%	70
2016 Q4	$2.6M	Sell	41,542 -4,141	-9%	-$253K	0.34%	70
2016 Q3	$2.88M	Sell	45,683 -25,447	-36%	-$1.65M	0.39%	67
2016 Q2	$4.4M	Sell	71,130 -3,779	-5%	-$230K	0.59%	58
2016 Q1	$4.28M	Buy	74,909 +716	+1%	+$39.9K	0.61%	59
2015 Q4	$4.4M	Sell	74,193 -200	-0.3%	-$11.5K	0.61%	57
2015 Q3	$4.05M	Buy	74,393 +231	+0.3%	+$15K	0.62%	55
2015 Q2	$4.98M	Sell	74,162 -4,490	-6%	-$293K	0.71%	53
2015 Q1	$4.6M	Sell	78,652 -383	-0.5%	-$23.1K	0.65%	54
2014 Q4	$5.17M	Sell	79,035 -1,187	-1%	-$74.8K	0.73%	51
2014 Q3	$4.63M	Sell	80,222 -11,766	-13%	-$653K	0.7%	54
2014 Q2	$5.19M	Sell	91,988 -3,918	-4%	-$206K	0.74%	53
2014 Q1	$4.93M	Sell	95,906 -103,487	-52%	-$5.23M	0.72%	54
2013 Q4	$10.5M	Sell	199,393 -4,167	-2%	-$205K	1.57%	20
2013 Q3	$9.11M	Sell	203,560 -146,035	-42%	-$6.47M	1.46%	23
2013 Q2	$14.5M	Buy	+349,595	New	+$15.3M	1.6%	23

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stock Yards Bank & Trust's ABBV Position: Q1 2026 in Review

Stock Yards Bank & Trust reduced its AbbVie (ABBV) stake by 5% in Q1 2026, selling an estimated $675K and leaving 57,876 shares worth $12.6M. The position accounts for 0.39% of the portfolio, ranked #59.

Stock Yards Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.8M in Q3 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Stock Yards Bank & Trust held 57,876 shares of AbbVie worth $12.6M as of Q1 2026.
Stock Yards Bank & Trust sold 3,045 AbbVie shares in Q1 2026, an estimated $675K.
AbbVie made up 0.39% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #59 holding.
Stock Yards Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Stock Yards Bank & Trust's AbbVie position peaked at $14.8M in Q3 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.